Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBDIX vs BIB overlap: 32% of top holdings shared

Bottom line

How much do FBDIX and BIB overlap?

32% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 26.9% of FBDIX's assets and 21.8% of BIB's. They share a meaningful core but differ in the rest of the portfolio.

BIB holds far more positions (267 vs 126), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FBDIXBIB
Weight overlap (top 25)32%
Shared holdings8
Weight in shared holdings26.9%21.8%
Total positions126267
Expense ratio1.01%0.95%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FBDIX and BIB have in common

Holding% of FBDIX% of BIBOverlap
Amgen, Inc.4.39%4.48%4.39%
Gilead Sciences, Inc.3.86%4.66%3.86%
Regeneron Pharmaceuticals, Inc.3.77%3.21%3.21%
Argenx SE3.62%1.19%1.19%
Vertex Pharmaceuticals, Inc.3.54%4.65%3.54%
Revolution Medicines, Inc.3.01%1.57%1.57%
Guardant Health, Inc.2.76%0.85%0.85%
Insmed, Inc.1.99%1.16%1.16%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBDIX

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  3. Ascendis Pharma A/S — 2.56%
  4. Dianthus Therapeutics, Inc. — 2.32%
  5. Mirum Pharmaceuticals, Inc. — 1.98%
  6. Praxis Precision Medicines, Inc. — 1.91%
  7. Spyre Therapeutics, Inc. — 1.87%
  8. Oruka Therapeutics, Inc. — 1.86%
  9. Neurocrine Biosciences, Inc. — 1.82%
  10. Bridgebio Pharma, Inc. — 1.67%
  11. PTC Therapeutics, Inc. — 1.65%
  12. AstraZeneca plc — 1.51%
  13. Franklin Institutional U.S. Government Money Market Fund — 1.45%
  14. Amylyx Pharmaceuticals, Inc. — 1.32%
  15. Eli Lilly & Co. — 1.31%

Only in BIB

  1. N/a — 7.35%
  2. ProShares GENIUS Money Market ETF — 6.80%
  3. N/a — 3.94%
  4. N/a — 3.26%
  5. N/a — 2.62%
  6. Alnylam Pharmaceuticals, Inc. — 2.01%
  7. Biogen, Inc. — 1.44%
  8. Repurchase Agreement — 1.28%
  9. Illumina, Inc. — 1.25%
  10. United Therapeutics Corp. — 1.22%
  11. Royalty Pharma plc — 1.20%
  12. N/a — 1.18%
  13. Roivant Sciences Ltd. — 1.08%
  14. Incyte Corp. — 0.97%
  15. Viatris, Inc. — 0.94%

Asset mix

Asset typeFBDIXBIB
Stocks97.0%63.0%
Equity derivatives—16.0%
Other0.6%6.8%
Cash & short-term funds4.6%0.8%
Repurchase agreements—3.1%
Preferred stock1.0%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFBDIXBIB
US82.0%79.8%
IE6.7%1.2%
NL4.5%1.6%
DK2.6%0.8%
FR1.7%1.0%
GB1.5%1.7%
CA1.3%0.6%
CH1.2%0.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FBDIX and BIB overlap?
About 32% by weight. 8 securities appear in both funds' top 25 holdings; they make up 26.9% of FBDIX's assets and 21.8% of BIB's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBDIX and BIB have in common?
The largest shared holdings are Amgen, Inc., Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Revolution Medicines, Inc..
Should I own both FBDIX and BIB?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBDIX or BIB?
BIB is broader, with 267 positions versus 126 for FBDIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.